Send to a Friend Font Size: Increase Decrease

Viking Global Investors

Viking Global Investors 's Portfolio

Last Updated on 5/16/11 @ 05:55pm

Ticker	# of Shares	Price	Value
	143,085,126	$1,141.93	$163,393,197,934
	120,000,000	$1,141.93	$137,031,600,000
	75,238,700	$1,141.93	$85,917,328,691
	9,798,229	$1,141.93	$11,188,891,642
	6,639,199	$1,141.93	$7,581,500,515
	6,524,565	$1,141.93	$7,450,596,511
	5,943,261	$1,141.93	$6,786,788,034
	4,787,914	$1,141.93	$5,467,462,635
	4,400,000	$1,141.93	$5,024,492,000
	4,194,777	$1,141.93	$4,790,141,700
View Additional Portfolio Information »

Viking Global Investors is a long/short equity hedge fund. The fund employs a bottom-up fundamental stock-picking strategy for its investments in equities in the U.S. and Europe. It focuses on the financial, telecommunication, media, technology, and consumer sectors. Viking Global Investors is based in New York and was founded in October, 1999 by Andreas Halvorsen, David Ott, and Brian Olson.

Messers. Halvorsen, Ott, and Olson worked together at Tiger Management Corp. All three left Tiger in early 1999.

Login to help us fill in information about this entity.

View Older Stories View More Recent Stories

Aug 29, 2023 09:01AM Inhibrx Inc. (INBX) Announces $200M Financing at $19.35/sh
Aug 24, 2023 04:30PM Form SC 13G VALVOLINE INC Filed by: VIKING GLOBAL INVESTORS LP
Aug 14, 2023 04:25PM Form 13F-HR VIKING GLOBAL INVESTORS For: Jun 30
Jul 20, 2023 06:02AM Form SC 13D/A BridgeBio Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Jul 19, 2023 09:34PM Form 4 BridgeBio Pharma, Inc. For: Jul 18 Filed by: VIKING GLOBAL INVESTORS LP
Jul 18, 2023 09:31PM Form 144 BridgeBio Pharma, Inc. Filed by: Viking Global Opportunities Illiquid Investments Sub-Master LP
Jun 26, 2023 05:12PM Form 4 Roivant Sciences Ltd. For: Jun 22 Filed by: Viking Global Opportunities GP LLC
Jun 26, 2023 05:06PM Form SC 13G/A Roivant Sciences Ltd. Filed by: VIKING GLOBAL INVESTORS LP
Jun 20, 2023 04:31PM Form SC 13G NewAmsterdam Pharma Co Filed by: VIKING GLOBAL INVESTORS LP
Jun 16, 2023 04:18PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Jun 5, 2023 05:00PM Form SC 13G Verastem, Inc. Filed by: VIKING GLOBAL INVESTORS LP
May 16, 2023 05:28PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
May 15, 2023 04:21PM Form 13F-HR VIKING GLOBAL INVESTORS For: Mar 31
May 11, 2023 05:51PM Form 4 4D Molecular Therapeutic For: May 09 Filed by: Viking Global Opportunities GP LLC
Apr 27, 2023 04:33PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Mar 21, 2023 04:46PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Mar 7, 2023 07:32AM Cazoo (CZOO) Provides Year-to-Date Business Performance Update
Mar 3, 2023 09:41AM Form D/A Viking Global Equities
Mar 3, 2023 09:40AM Form D/A Viking Global Equities
Mar 3, 2023 09:38AM Form D/A Viking Global Equities
Feb 27, 2023 05:11PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Feb 22, 2023 04:16PM Cazoo (CZOO) Sells Cazana Data Platform
Feb 17, 2023 09:00AM Cazoo (CZOO) Agrees Sale of German Subscription Business
Feb 14, 2023 03:38PM Form 13F-HR VIKING GLOBAL INVESTORS For: Dec 31
Feb 14, 2023 01:19PM Form SC 13G/A Pharvaris N.V. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:19PM Form SC 13G/A Guardant Health, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:19PM Form SC 13G/A Amylyx Pharmaceuticals, Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:19PM Form SC 13G/A Trevi Therapeutics, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:19PM Form SC 13G/A Inhibrx, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:19PM Form SC 13G/A FIGS, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:19PM Form SC 13G/A APi Group Corp Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:18PM Form SC 13G/A STANDARD BIOTOOLS INC. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:18PM Form SC 13G/A Ginkgo Bioworks Holdings Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:18PM Form SC 13G/A Celldex Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:18PM Form SC 13G/A PepGen Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:18PM Form SC 13G/A Coupa Software Inc Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:18PM Form SC 13G/A Edgewise Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:18PM Form SC 13G/A Orion Acquisition Corp. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:18PM Form SC 13G/A PROCEPT BioRobotics Corp Filed by: VIKING GLOBAL INVESTORS LP
Feb 7, 2023 04:13PM Cazoo (CZOO) Announces Reverse Stock Split and Increase in Authorized Share Capital
Jan 18, 2023 06:32AM Cazoo (CZOO) Reports Prelim Q4 Results, Revises 2023 Guidance
Jan 6, 2023 07:00AM Form D/A Viking Global Opportunit
Jan 6, 2023 06:55AM Form D/A Viking Global Opportunit
Dec 15, 2022 08:05AM Cazoo (CZOO) Sells Its Spanish Subscription Business
Dec 12, 2022 08:02AM Whole Earth Brands (FREE) Announces CEO Transition Plan
Nov 25, 2022 01:44PM Form SC 13D/A Frazier Lifesciences Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2022 04:19PM Form 13F-HR VIKING GLOBAL INVESTORS For: Sep 30
Nov 10, 2022 04:57PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Nov 10, 2022 08:01AM Cazoo (CZOO) Noteholders Voluntarily Extend Lock-Up Period
Nov 3, 2022 05:13PM Form SC 13D Frazier Lifesciences Filed by: VIKING GLOBAL INVESTORS LP

View More Recent Stories View Older Stories

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed